Three doses of Pfizer and BioNTech’s Covid-19 vaccine were effective in preventing symptomatic cases in children ages 6 months to 4 years in studies, according to US health regulators. The FDA team also said, in a review of study data published online Sunday, that there were no new safety concerns about using the vaccine in young children compared to older age groups.
The assessment is the latest sign that authorities are moving closer to releasing vaccines for children under age 5, the last group not eligible for Covid-19 vaccination.
On Friday, the FDA released a review pointing out that two doses of Moderna’s Covid-19 vaccine are generally safe and effective in children ages 6 months to 5 years.
The FDA could make a decision next week on whether to authorize the two vaccines for use among young children, after vaccine experts advising the agency consider the data on the vaccines and make a recommendation.
#FDA #doses #Pfizer #covid #effective #safe #range #years